EP Patent

EP2353594A1 — Compositions comprising tramadol and the co-crystal of celecoxib and L-proline in the treatment of pain

Assigned to Esteve Pharmaceuticals SA · Expires 2011-08-10 · 15y expired

What this patent protects

The present invention relates to a compound combination of tramadol and a co-crystal of celecoxib ۥ L-proline or a pharmaceutical composition comprising it and their uses as medicaments, more particularly for the treatment of pain.

USPTO Abstract

The present invention relates to a compound combination of tramadol and a co-crystal of celecoxib ۥ L-proline or a pharmaceutical composition comprising it and their uses as medicaments, more particularly for the treatment of pain.

Drugs covered by this patent

Patent Metadata

Patent number
EP2353594A1
Jurisdiction
EP
Classification
—
Expires
2011-08-10
Drug substance claim
No
Drug product claim
No
Assignee
Esteve Pharmaceuticals SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.